Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Kaumil Gajrawala

Nvidia, Tilray, Offerpad, Interactive Brokers And Keurig Dr Pepper: Why These 5 Stocks Are On Investors' Radars Today

U.S. stocks closed lower on Monday, with the Dow Jones Industrial Average slipping almost 0.8% to 45,282.47, the SP 500 easing 0.4% to 6,439.32, and the Nasdaq finishing 0.2% lower at 21,449.29.These are the top stocks that gained the attention of retail traders and investors throughout the day. Nvidia Corporation…

Jefferies Just Raised Its Tilray Stock Price Target 33%. Should You Buy TLRY Here?

Jefferies Just Raised Its Tilray Stock Price Target 33%. Should You Buy TLRY Here?

Tilray stock extends gains as Jefferies raises its price target on the cannabis firm to $2. But caution is warranted as TLRY shares are already up some 300% versus their year-to-date low.

PepsiCo CEO was grilled about GLP-1s by a 13-year-old on his Q1 conference call

PepsiCo CEO was grilled about GLP-1s by a 13-year-old on his Q1 conference call

The CEO responded seriously with a mention of the company’s “fiber and hydration solutions.”

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Strong Fundamentals But Valuation High: Why Analysts Are On The Sidelines Of Pepsi Stock

Beverage and snack food company PepsiCo, Inc. (NYSE: PEP) reported second-quarter financial results before market open Tuesday.

Credit Suisse Cuts Price Target On This Consumer Goods Giant- Read Why

Credit Suisse analyst Kaumil Gajrawala lowered the price target of Colgate-Palmolive Co (NYSE: CL) to $90 from $95 and kept an Outperform rating on the shares, implying a 9.3% upside.

Credit Suisse Downgrades This Cleaning Products Manufacturer - Read Why

Credit Suisse analyst Kaumil Gajrawala downgraded Clorox Co (NYSE:CLX) to Underperform from Neutral with a $160 price target. The analyst thinks a large portion of Clorox's growth during the first phase of the pandemic came from categories that are now declining. If consumption continues to revert toward pre-pandemic levels, $500 million in company sales may…

People

Shivdeep Dhaliwal

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

NVIDIA Corporation

Walgreens Boots Alliance

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

303,073 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play